BAXTER HEALTHCARE CORPORATION; SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE
|
Back to Search Results |
|
Device Problems
Contamination (1120); Improper or Incorrect Procedure or Method (2017)
|
Patient Problem
Peritonitis (2252)
|
Event Date 05/30/2014 |
Event Type
Injury
|
Event Description
|
It was reported that a patient experienced a breach in aseptic technique during peritoneal dialysis (pd) therapy, which resulted in peritonitis.The breach in aseptic technique was further described as patient made a mistake/touch contamination.The patient was hospitalized for the peritonitis.The patient was treated with ceftazidime(1gram daily for 3 weeks, route not reported) for peritonitis.The patient was discharged from the hospital two weeks after being admitted.It was reported that the patient was recovered from the peritonitis.It was not reported if the patient would be retrained or if the patient had been retrained on aseptic technique.Pd therapy was ongoing.Additional information was requested but is not available.
|
|
Manufacturer Narrative
|
(b)(4).This is a report of a use error that resulted in peritonitis.Per baxter labeling, users are instructed to use aseptic technique when performing peritoneal dialysis therapy. a review of the label for the product family will be conducted.Should additional relevant information become available, a supplemental report will be submitted.
|
|
Search Alerts/Recalls
|
|
|